跳至主要内容
临床试验/NCT03442660
NCT03442660已完成不适用

Psychometric Validation Study of the Spasticity Quality of Life 6-Dimensions (SQOL-6D) in Upper-limb Spasticity

Ipsen16 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2018年5月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Ipsen
入组人数
104
试验地点
16
主要终点
Validation of SQOL-6D in upper limb spasticity

研究概览

简要总结

The purpose of the study is to describe the psychometric properties (validity, reliability and responsiveness) of the SQOL-6D instrument in the context of routine clinical treatment of upper limb spasticity.

详细描述

The study qualifies as interventional not because of the use of an investigational product, but because the imposed specific data collection procedures include multiple questionnaire assessments and one on-site visit not necessarily part of routine clinical practice.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Currently resident in the UK
  • Subjects with a diagnosis of ULS
  • Receiving a treatment at the enrolment visit, as part of their routine clinical management, aiming at reducing spasticity
  • Sufficient grasp of English and cognitive ability to be able to understand the SQOL-6D questions, give informed consent and complete the protocol requirements as judged by the investigator

排除标准

  • The subject has already been included in the study
  • The subject, in the opinion of the investigator, would be unable to understand the questionnaire or to comply with the requirements of the study

研究组 & 干预措施

Data collection

Other

An electronic data capture (EDC) system will be used to collect data in electronic format. Data will be collected at the enrolment visit, at the follow-up visit (8 weeks +/-2 weeks) and 1 to 4 days after the follow-up visit.

干预措施: Data collection (Other)

结局指标

主要结局

Validation of SQOL-6D in upper limb spasticity

时间窗: Change from baseline (day 1) to 8 weeks +/-2 weeks (follow up visit)

Validity - Reliability - Responsiveness

次要结局

  • EQ-5D-5L (EuroQoL 5 Dimensions, 5 Levels)(Day 1 and then 8 weeks +/-2)
  • Neurological Impairment Scale adapted for ULS (ULS-NIS)(Day 1)
  • Modified Ashworth Scale (MAS)(Day 1 and then 8 weeks +/-2)
  • Gaseous (Goal Attainment Scaling Evaluation of Outcome for Upper-Limb Spasticity)(Day 1 and then 8 weeks +/-2)
  • ArmA (Arm Activity Measure) Scores(Day 1 and then 8 weeks +/-2)
  • Global assessment of benefit(8 weeks +/-2)

研究者

发起方
Ipsen
申办方类型
Industry
责任方
Sponsor

研究点 (16)

Loading locations...

相似试验

Validation of the Spasticity Related Quality of Life... | 临床试验